Enhanced Method Development
1:02:04
Enhanced Method Development
Share
Related Videos
In Biopharma & Pharma
-
Play video Native Mass Spectrometry to Probe Conformational Landscape of Intrinsically Disordered Proteins
Native Mass Spectrometry to Probe Conformational Landscape of Intrinsically Disordered Proteins
Learn about native mass spectrometry to probe conformational landscape of intrinsically disordered proteins
16:17
-
Play video 30 Years of Biomedical Discovery with Q-TOF Mass Spectrometry - Prof Howard Morris
30 Years of Biomedical Discovery with Q-TOF Mass Spectrometry - Prof Howard Morris
Presented by a leader in the development of this groundbreaking technology, Prof. Morris highlights key discoveries enabled by Q-TOF
39:30
-
Play video USP 621 Revisions - S/N Calculation, Sensitivity and Peak Symmetry
USP 621 Revisions - S/N Calculation, Sensitivity and Peak Symmetry
USP 621 Revisions - S/N Calculation, Sensitivity and Peak Symmetry
1:01:16
-
Play video Webinar - Intact and Subunit LC-MS Characterization of mAbs and msAbs using Advanced Protein A Columns
Webinar - Intact and Subunit LC-MS Characterization of mAbs and msAbs using Advanced Protein A Columns
This webinar introduces a Protein A-MS pH-elution gradient method using BioResolve Protein A Affinity Columns to effectively separate protein variants with modulated binding affinities before direct intact high-resolution MS analysis.
55:27
-
Play video Structural Heterogeneity of Adeno-Associated Virus Vector for Gene Therapy
Structural Heterogeneity of Adeno-Associated Virus Vector for Gene Therapy
Learn how Prof Uchiyama and his team are developing methods to characterize adeno-associated virus (AAV) vectors for gene therapy to ensure their efficacy and safety
23:15
-
Play video Episode 1 USP 621 Harmonization
Episode 1 USP 621 Harmonization
USP 621 Harmonization - Method Scaling
1:02:21
